Vistagen Therapeutics Inc Sustainability Reports
A late clinical-stage biopharmaceutical company developing intranasal product candidates called pherines to treat CNS disorders like social anxiety, depression, and mental fatigue.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001S67BH3
2 reports from 2021 to 2023